Takeda to invest 25m and create up to 70 new roles

TiGenix and Takeda Pharmaceutical Company Limited last week announced that the European Commission has approved Alofisel previously Cx601 for the treatment of complex perianal fistulae in adult patients with nonactivemildly active luminal Crohn&39;s d...